1. Reflections on the Evolution of Patient Engagement in Drug Development

   • Kenneth Getz

   Current Opinion 17 May 2019 Pages: 179 - 185

2. Genome Editing: Promoting Responsible Research

   • François Hirsch
   • Christine Lemaitre
   • Lluis Montoliu

   Current Opinion 04 April 2019 Pages: 187 - 191

3. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector

   • Maria Angeles Martinez-Grau
   • Maria Alvim-Gaston

   Current Opinion 26 April 2019 Pages: 193 - 198

   

4. Regulatory Capture in Pharmaceutical Policy Making: The Case of National Medicine Agencies Related to the EU Falsified Medicines Directive

   • Rasmus Borup
   • Janine Morgall Traulsen
   • Susanne Kaae

   Original Research Article 02 April 2019 Pages: 199 - 207

   

5. Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data

   • Angelo Del Parigi
   • Wenbo Tang
   • Richard Pratley

   Original Research Article Open access 20 May 2019 Pages: 209 - 217

   

6. Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures

   • Laurie J. Zografos
   • Elizabeth Andrews
   • Zdravko P. Vassilev

   Original Research Article Open access 26 April 2019 Pages: 219 - 233

   

7. Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures

   • Laurie J. Zografos
   • Elizabeth Andrews
   • Zdravko P. Vassilev

   Original Research Article Open access 27 April 2019 Pages: 235 - 246

   

8. Forum

   Update 10 May 2019 Pages: 247 - 256

9. Major Pharmaceutical Conferences and Courses

   Update 14 May 2019 Pages: 257 - 259